ArGEN-X NV has raised an additional €1.8 million from its initial public offering on the Euronext stock exchange in Brussels following the partial exercise of an over-allotment option by one of the underwriters. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
